130 related articles for article (PubMed ID: 38682958)
41. Acute hemolytic transfusion reaction caused by anti-Yt
Raos M; Thornton N; Lukic M; Golubic Cepulic B
Immunohematology; 2021 Mar; 37(1):13-17. PubMed ID: 33962487
[TBL] [Abstract][Full Text] [Related]
42. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
43. Severe hemolysis resulting from D incompatibility in a case of ABO-identical liver transplant.
Fung MK; Sheikh H; Eghtesad B; Lopez-Plaza I
Transfusion; 2004 Nov; 44(11):1635-9. PubMed ID: 15504170
[TBL] [Abstract][Full Text] [Related]
44. Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab.
Fuja C; Kothary V; Carll TC; Singh S; Mansfield P; Wool GD
Transfusion; 2022 Jul; 62(7):1446-1451. PubMed ID: 35588309
[TBL] [Abstract][Full Text] [Related]
45. Moderate hemolytic disease of the newborn due to anti-Hr0 in a mother with the D--/D-- phenotype.
Lenkiewicz B; Zupanska B
Immunohematology; 2000; 16(3):109-11. PubMed ID: 15373614
[TBL] [Abstract][Full Text] [Related]
46. In search of red blood cells for alloimmunized patients with sickle cell disease.
Flickinger C
Immunohematology; 2006; 22(3):136-42. PubMed ID: 17105363
[TBL] [Abstract][Full Text] [Related]
47. Prolonged anemia in an intrauterine-transfused neonate with Rh-hemolytic disease: no evidence for anti-D-related suppression of erythropoiesis in vitro.
Dorn I; Schlenke P; Härtel C
Transfusion; 2010 May; 50(5):1064-70. PubMed ID: 20003047
[TBL] [Abstract][Full Text] [Related]
48. Rate of RhD-alloimmunization after the transfusion of multiple RhD-positive primary red blood cell-containing products.
Yazer MH; Triulzi DJ; Sperry JL; Seheult JN
Transfusion; 2021 Jul; 61 Suppl 1():S150-S158. PubMed ID: 34269438
[TBL] [Abstract][Full Text] [Related]
49. Incompatible red blood cell transfusion for hemolytic disease of the fetus and newborn secondary to anti-U: A case report.
Badawi MA; Al-Wassia H
Transfusion; 2023 Feb; 63 Suppl 1():S28-S32. PubMed ID: 36748668
[TBL] [Abstract][Full Text] [Related]
50. Anti-f in a 24-year-old male: a case study.
Jator EK; Pedde E
Clin Lab Sci; 2010; 23(2):68-71. PubMed ID: 20499529
[TBL] [Abstract][Full Text] [Related]
51. Hemoglobin-Based Oxygen Carrier (HBOC) Development in Trauma: Previous Regulatory Challenges, Lessons Learned, and a Path Forward.
Keipert PE
Adv Exp Med Biol; 2017; 977():343-350. PubMed ID: 28685464
[TBL] [Abstract][Full Text] [Related]
52. Mechanisms responsible for delayed and immediate hemolytic transfusion reactions in a patient with anti-E + Jk(b)+ Di(b) and anti-HLA alloantibodies.
Okamoto T; Hashimoto M; Samejima H; Mori A; Wakabayashi M; Takeda A; Nakamura H; Naruse H; Bouike Y; Araki N
Immunopharmacol Immunotoxicol; 2004; 26(4):645-52. PubMed ID: 15658612
[TBL] [Abstract][Full Text] [Related]
53. Rh blood group-specific antibodies in immune hemolytic anemia induced by nomifensine.
Salama A; Mueller-Eckhardt C
Blood; 1986 Dec; 68(6):1285-8. PubMed ID: 3096400
[TBL] [Abstract][Full Text] [Related]
54. Hemoglobin A clearance in children with sickle cell anemia on chronic transfusion therapy.
Yee MEM; Josephson CD; Winkler AM; Webb J; Luban NLC; Leong T; Stowell SR; Roback JD; Fasano RM
Transfusion; 2018 Jun; 58(6):1363-1371. PubMed ID: 29664198
[TBL] [Abstract][Full Text] [Related]
55. [Significance of alloantibodies other than anti-D hemolytic disease of the fetus and newborn (HDF/N)].
Lenkiewicz B; Zupańska B
Ginekol Pol; 2003 Jan; 74(1):48-54. PubMed ID: 12715437
[TBL] [Abstract][Full Text] [Related]
56. The reduction of the allogenic transfusion requirement in aortic surgery with a hemoglobin-based solution.
LaMuraglia GM; O'Hara PJ; Baker WH; Naslund TC; Norris EJ; Li J; Vandermeersch E
J Vasc Surg; 2000 Feb; 31(2):299-308. PubMed ID: 10664499
[TBL] [Abstract][Full Text] [Related]
57. Acute and delayed hemolytic transfusion reactions secondary to HLA alloimmunization.
Benson K; Agosti SJ; Latoni-Benedetti GE; Leparc GF
Transfusion; 2003 Jun; 43(6):753-7. PubMed ID: 12757526
[TBL] [Abstract][Full Text] [Related]
58. The value of transfusion of phenotyped blood units for thalassemia and sickle cell anemia patients at an academic center.
Hindawi S; Badawi M; Elfayoumi R; Elgemmezi T; Al Hassani A; Raml M; Alamoudi S; Gholam K
Transfusion; 2020 Feb; 60 Suppl 1():S15-S21. PubMed ID: 32134130
[TBL] [Abstract][Full Text] [Related]
59. A cold case of hemolytic disease of the fetus and newborn resolved by genomic sequencing and population studies to define a new antigen in the Rh system.
Wilson B; Davison CL; Lopez GH; Millard GM; Liew YW; Powley T; Campbell T; Jadhao SS; Nagaraj SH; Perry M; Roulis EV; Toombs M; Irving DO; Flower RL; Hyland CA
Transfusion; 2024 Jun; 64(6):1171-1176. PubMed ID: 38686705
[TBL] [Abstract][Full Text] [Related]
60. Effect of facility-level hemoglobin concentration on dialysis patient risk of transfusion.
Collins AJ; Monda KL; Molony JT; Li S; Gilbertson DT; Bradbury BD
Am J Kidney Dis; 2014 Jun; 63(6):997-1006. PubMed ID: 24315770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
